Cancer Weekly articles from October 2000

Cancer Weekly archives from October 2000

Combination of Debulking Surgery and Radiotherapy Effective.
October 3, 2000... 2000 OCT 3 - (NewsRx.com) -- Combining debulking surgery with high-dose radiotherapy can dramatically increase the chances of disease-free survival in patients with locally advanced paranasal sinus carcinoma. "As most patients present...

Aggressive Non-Melanoma Cancer on Neck and Face Requires Diverse Treatment Strategies to Preclude Recurrence.
October 3, 2000... 2000 OCT 3 - (NewsRx.com) -- Non-melanoma skin cancer (NMSC), which includes basal cell carcinoma (BCC) and squamous cell carcinoma (SCC), is the most common malignancy to affect humans. In the United States, incidence is at an epidemic...

Tumor-Activated Prodrug for Colorectal, Pancreatic Cancers Enters Second Phase I/II Trial.
October 3, 2000... 2000 OCT 3 - (NewsRx.com) -- ImmunoGen, Inc. (IMGN) announced that huC242-DM1/SB-408075, its lead Tumor-Activated Prodrug (TAP) for the treatment of colorectal and pancreatic cancers, has entered a second Phase I/II clinical trial. ...

Grant To Focus on Nitric Oxide-releasing Compounds.
October 3, 2000... 2000 OCT 3 - (NewsRx.com) -- NicOx S.A. (NICOX), Sophia Antipolis, France, announced that a grant has been awarded by the U.S. National Cancer Institute (NCI) of the U.S. National Institutes of Health (NIH) to scientists at the American...

Cancer Centers to Help Parents.
October 3, 2000... 2000 OCT 3 - (NewsRx.com) -- Deborah Pryce is a lawyer, former judge, and a member of the U.S. Congress. Yet she felt helpless and "almost frozen with fear" when forced to select the right treatment for her daughter's cancer. "We got...

Approval Received for BrachySeed Treatment.
October 3, 2000... 2000 OCT 3 - (NewsRx.com) -- Draxis Health Inc. (DRAX; DAX), Mississauga, Ontario, Canada, and Cytogen Corp. (CYTO), Princeton, New Jersey, announced that Draxis' wholly-owned radiopharmaceutical subsidiary, Draximage, has received U.S....

Gemcitabine/Etoposide Therapy Causes Hepatic Dysfunction in HBV(+) Lung Cancer Patients.
October 3, 2000... 2000 OCT 3 - (NewsRx.com) -- Phase II clinical trials have shown that gemcitabine, when used in conjunction with etoposide for treating lung cancer patients, can cause some side effects, including hepatic dysfunction in patients who are...

Single-chain Fv Antibody Binds Vascular Endothelial Growth Factor Complexes.
October 3, 2000... 2000 OCT 3 - (NewsRx.com) -- A new antibody that targets vascular endothelial growth factor (VEGF) complexes has been identified by researchers at a major research institution in London. This antibody, called LL4, was discussed by the...

Updated Clinical Trial Results for Cancer Therapies Presented.
October 3, 2000... 2000 OCT 3 - (NewsRx.com) -- Dr. Raymond P. Warrell, Jr., Genta Inc. (GNTA), presented an update of the company's ongoing clinical trials, along with plans for future registration studies that the company expects to initiate over the next...

Estradiol Level May Indicate Who Benefits Most from Raloxifene Treatment.
October 3, 2000... 2000 OCT 3 - (NewsRx.com) -- The level of estradiol, the most potent form of estrogen, may determine how much postmenopausal women benefit from treatment with raloxifene to reduce the risk of breast cancer. Steven R. Cummings, MD, of...

Alternative Method of Drug Delivery Enhances Chemotherapy Effectiveness.
October 3, 2000... 2000 OCT 3 - (NewsRx.com) -- A different way of administering chemotherapy to patients who suffer from obstructing esophageal cancer could potentially extend survival. "Obstructing esophageal cancer produces severe dysphagia with...

Study Suggests Olive Oil May Be Protective.
October 3, 2000... 2000 OCT 3 - (NewsRx.com) -- Olive oil seems to protect against bowel cancer, suggests research involving 28 countries. Researchers analyzed information from databases from the International Agency for Research in Cancer (IARC),...

Accelerated Radiotherapy Fractionation Increases Effectiveness and Radiation Toxicity.
October 3, 2000... 2000 OCT 3 - (NewsRx.com) -- An accelerated schedule of radiation therapy can increase the effectiveness of the treatment for head and neck cancer, but it can also increase the severity of adverse side effects. "The optimal...

Higher Doses of Methotrexate Dramatically Improve Survival for Some Patients.
October 3, 2000... 2000 OCT 3 - (NewsRx.com) -- High-dose chemotherapy offers up to five times longer survival to patients with primary central nervous system (CNS) lymphoma, an aggressive non-Hodgkin's lymphoma of the brain, eyes, or spinal cord. ...

Selective COX-2 Inhibitors May Help Prevent Metastases.
October 3, 2000... 2000 OCT 3 - (NewsRx.com) -- Drugs that block the expression of cyclooxygenase enzymes, particularly cyclooxygenase-2 (COX-2), already known to be effective in the treatment of painful inflammatory conditions, may also be useful in...

Estimated Cell Percentage is Prognostic of Recurrence After Radical Prostatectomy.
October 3, 2000... 2000 OCT 3 - (NewsRx.com) -- The visual estimation of the percentage of tumor cells in prostate tissue specimens from patients who undergo radical prostatectomy is a simple, inexpensive method for obtaining independent prognostic...

New Study Suggests Screening Should Be Done Earlier, Every Two Years.
October 3, 2000... 2000 OCT 3 - (NewsRx.com) -- Although medical scientists still debate the effectiveness of prostate cancer screening, known as serum prostate-specific antigen (PSA) testing, and even of prostate cancer treatments themselves, the PSA...

Licorice Root Derivative Demonstrates Anti-Tumor and Estrogenic Properties.
October 3, 2000... 2000 OCT 3 - (NewsRx.com) -- Some derivates of licorice root have been shown to demonstrate estrogenic properties. Moreover, some of those derivatives have been shown to express anti-tumor properties. One of those derivatives,...

Radiotherapy Booster Cuts Risk of Recurrence.
October 3, 2000... 2000 OCT 3 - (NewsRx.com) -- A major international trial has produced the first firm evidence that giving extra radiotherapy to patients with early breast cancer substantially reduces the risk of cancer recurring in the breast. The...

Research on Gene Therapy Plus Radiation Therapy Reported.
October 3, 2000... 2000 OCT 3 - (NewsRx.com) -- New gene therapy techniques can enhance the action of radiation therapy, researchers at the European Society for Therapeutic Radiology and Oncology Conference in Istanbul reported on September 21, 2000. ...

Glycoconjugate Vaccine Formulation Enhances Immunogenicity of Tumor-Associated Antigen.
October 3, 2000... 2000 OCT 3 - (NewsRx.com) -- According to a study from Italy, a new glycoconjugate vaccine formulation enhances the immunogenicity of the tumor-associated antigen CaMBr1. "Aberrant glycosylation is one of the most constant traits of...

Cytokines Stimulate Graft-versus-Leukemia Effect Against Relapse.
October 3, 2000... 2000 OCT 3 - (NewsRx.com) -- In a case of leukemic relapse after unrelated umbilical cord blood transplantation for hematopoietic reconstitution, researchers in the United States used interleukin (IL)-2 to stimulate an aggressive...

High Glycemic Load Increases Risk of Colorectal Cancer.
October 3, 2000... 2000 OCT 3 - (NewsRx.com) -- Eating a diet with a high glycemic index or glycemic load can lead to a marked increase the risk of developing colorectal cancer, researchers report. "Insulin and insulin-like growth factors can stimulate...

Suicide Gene Therapy/Cytokine Vaccine Effective Against Brain Tumors.
October 3, 2000... 2000 OCT 3 - (NewsRx.com) -- Brain tumors appear to be sensitive to suicide gene therapy approaches. "The aim of our experiments is to develop new therapeutical approaches for the treatment of brain tumors," stated Drs. Szilvia...

Group Seeks Changes in Brachytherapy Seed Reimbursement.
October 3, 2000... 2000 OCT 3 - (NewsRx.com) -- The American Society for Therapeutic Radiology and Oncology (ASTRO) is collecting data from its members on their use of High Dose Rate (HDR) brachytherapy as part of a comprehensive effort to correct problems...

New Marker Shows Changes Created During Cervical Cancer.
October 3, 2000... 2000 OCT 3 - (NewsRx.com) -- An old protein may have a new use as a marker for cervical cancer, according to research scientists at the University of Illinois' College of Medicine. The protein, which is characterized as being a member...

Test Identifies Intact Cancer Cells in Peripheral Blood.
October 3, 2000... 2000 OCT 3 - (NewsRx.com) -- Researchers in Germany have developed a cellular approach that identifies morphologically intact cancer cells in the peripheral blood of patients with metastatic melanoma. "The detection of circulating...

Thalidomide Found to be Effective Treatment.
October 3, 2000... 2000 OCT 3 - (NewsRx.com) -- A Mayo Clinic study has found that thalidomide, a drug withdrawn nearly 40 years ago for causing birth defects, can be an effective medical treatment for multiple myeloma, an often fatal cancer that develops...

Alcohol is a Risk Factor When Combined with Genetic Influences.
October 3, 2000... 2000 OCT 3 - (NewsRx.com) -- Certain genetic polymorphisms can dramatically increase the risk of alcohol-induced cancer of the upper aerodigestive tract. "Ethanol is oxidized to acetaldehyde (the suspected carcinogenic agent in...

New Chemotherapy Regimen Far Less Toxic than Standard Treatment.
October 3, 2000... 2000 OCT 3 - (NewsRx.com) -- To improve safety and reduce toxicity, advanced bladder cancer patients can be treated with a combination of gemcitabine and cisplatin (GC) chemotherapy drugs, say researchers who conducted a large, randomized...

Thirteen "Core" Factors Account for Majority of Symptoms and Side Effects.
October 17, 2000... 2000 OCT 17 - (NewsRx.com) -- A list of 13 "core" items on a symptoms inventory accounted for approximately 64% of variability in symptom interference among cancer patients with various malignancies and stages of disease, according to a...

New First-Line Chemotherapy Treatment Developed for Metastatic Disease.
October 17, 2000... 2000 OCT 17 - (NewsRx.com) -- In an international study published in the September 28, 2000, issue of the New England Journal of Medicine, researchers at Memorial Sloan-Kettering Cancer Center report the development of a new chemotherapy...

High-Dose Chemotherapy Effective in Patients with Recurrent Disease.
October 17, 2000... 2000 OCT 17 - (NewsRx.com) -- High-dose chemotherapy followed by stem-cell transplantation offers new hope to testicular cancer patients who experience cancer recurrence. For these patients, such intensive therapy can achieve a...

Inhaled Isotretinoin Can Lower Risk of Lung and Aerodigestive Cancers While Minimizing Toxicity.
October 17, 2000... 2000 OCT 17 - (NewsRx.com) -- An inhaled form of isotretinoin can preserve the drug's effectiveness at preventing lung and aerodigestive cancer, while reducing its toxicity to tolerable levels, researchers writing in the journal Clinical...

Mutations in Newly Discovered Gene Result in Defective Mismatch Repair.
October 17, 2000... 2000 OCT 17 - (NewsRx.com) -- Researchers at Mayo Clinic have discovered that mutations in a newly isolated gene, AXIN2, lead to the development of colorectal cancer. This gene belongs to an important cell pathway that contains...

Long-Term Trials Indicate that Smaller Resection Margins Don't Compromise Results.
October 17, 2000... 2000 OCT 17 - (NewsRx.com) -- Study results from a multicenter, long-term, randomized trial published in the October 1, 2000, issue of Cancer show that melanoma patients with a tumor thickness of > 0.8 mm and "If the extent of surgery...

Prognostic Tool Can Help Patients Make Treatment Decisions.
October 17, 2000... 2000 OCT 17 - (NewsRx.com) -- Although advances in diagnostic testing for prostate cancer have improved the ability to detect the disease at an early stage, deciding which treatment approach will yield the most beneficial results for...

Link Made to Male Infertility.
October 17, 2000... 2000 OCT 17 - (NewsRx.com) -- Men who have infertility problems have an increased risk of developing testicular cancer, a new study reports. Sperm quality has possibly been falling over the past few decades while the rates of...

Therapy Receives FDA Approval to Treat Common Skin Lesions.
October 17, 2000... 2000 OCT 17 - (NewsRx.com) -- Berlex Laboratories, Inc., Montville, New Jersey, and DUSA Pharmaceuticals, Inc., Wilmington, Massachusetts, announced that the U.S. Food and Drug Administration (FDA) has granted approval of the commercial...

Oncologist: 2000 a Watershed Year.
October 17, 2000... 2000 OCT 17 - (NewsRx.com) -- The year 2000 marks a watershed in cancer research, a leading U.S. oncologist told a news briefing on September 28, 2000, at the 2nd European Breast Cancer Conference in Brussels. An explosion in genetic...

FDA Approves Arsenic Trioxide in Record Time for Cancer Drug Development Program.
October 17, 2000... 2000 OCT 17 - (NewsRx.com) -- The U.S. Food and Drug Administration (FDA) has approved Trisenox (arsenic trioxide) for the treatment of patients with acute promyelocytic leukemia (APL) who have not responded to, or have relapsed following...

Biological License Application to be Filed for Stage II Melanoma Vaccine.
October 17, 2000... 2000 OCT 17 - (NewsRx.com) -- Corixa Corporation (CRXA), a research and development-based biotechnology company, announced its intent to file for regulatory approval of its Melacine(R) melanoma vaccine. The biological license...

Phase III Clinical Trial Begins with Lymphoma Antibody.
October 17, 2000... 2000 OCT 17 - (NewsRx.com) -- Immunomedics, Inc. (IMMU), Morris Plains, New Jersey, announced that it is now beginning a Phase III, pivotal trial to study the safety, tolerability, and efficacy of its humanized, anti-CD22 monoclonal...

OraTest Clinical Study Moving Forward.
October 17, 2000... 2000 OCT 17 - (NewsRx.com) -- Zila, Inc. (Zila), Phoenix, Arizona, advised that the protocol for a Phase III clinical study in support of the company's OraTest oral cancer detection product was approved earlier by the U.S. Food and Drug...

New Drug Stops Growth of Human Tumors in Mice.
October 17, 2000... 2000 OCT 17 - (NewsRx.com) -- A new drug stopped the growth of human tumors in mice by targeting a growth factor essential for cancer cell survival, researchers at H. Lee Moffitt Cancer Center & Research Institute, University of South...

Select Enzyme Receptors Correlate with Cancer Invasion, Not Progression.
October 17, 2000... 2000 OCT 17 - (NewsRx.com) -- Scientists in South Korea report that certain types of receptors for proteolytic enzymes can be found more often during the early stages of breast cancer invasion, but aren't necessarily correlated with that...

Study Appears to Show Why Muscle Decays Mysteriously in Cancer, AIDS, Other Illnesses.
October 17, 2000... 2000 OCT 17 - (NewsRx.com) -- University of North Carolina at Chapel Hill scientists believe they have discovered a major reason why muscles often decay in patients with cancer, AIDS, late-stage heart disease, severe burns, and numerous...

Scientists to Try Altering Gene Carrier to Improve its Ability to Bind to Cancer Cells.
October 17, 2000... 2000 OCT 17 - (NewsRx.com) -- Although gene therapy has generated enormous enthusiasm in the scientific and lay communities for years because of its novel potential for treating disease, only recently is that potential being realized in...

Expert Calls for New Thinking on Clinical Trials and Drug Spending.
October 17, 2000... 2000 OCT 17 - (NewsRx.com) -- Major changes to the way clinical trials are conducted may be imperative to avoid unacceptable delays in getting new cancer treatments on to the market. Moreover, European countries will need to switch...

VEGF Receptor Agonist ZD6474 Causes Tumor Inhibition and Regression in Mice.
October 17, 2000... 2000 OCT 17 - (NewsRx.com) -- Researchers at AstraZeneca Pharmaceuticals announced at the British Cancer Research Meeting 2000 the results of their study of the vascular endothelial growth factor (VEGF) receptor tyrosine kinase inhibitor...

Combination Chemoimmunotherapy Regimen Results Are Mixed.
October 17, 2000... 2000 OCT 17 - (NewsRx.com) -- Results from a clinical trial of combination immunotherapy and chemotherapy for metastatic kidney carcinoma are mixed, researchers in Poland reported. "In the period between October 1997 and November 1999...

New Direct Assay Evaluates Tumor Peptide Vaccine Response.
October 17, 2000... 2000 OCT 17 - (NewsRx.com) -- A direct assay for determining immune reactivity of a cancer vaccine in melanoma patients has been developed. "Monitoring the immune response to epitope-specific vaccination in cancer patients is...

Interleukin-8 and Its Receptors May Promote Angiogenesis.
October 17, 2000... 2000 OCT 17 - (NewsRx.com) -- Medical researchers at the Connecticut Children's Medical Center in Hartford have performed laboratory studies that show the pro-angiogenic cytokine, interleukin (IL)-8, and its receptors are readily...

Clinical Trials Planned for First-Line Interferon Therapy.
October 17, 2000... 2000 OCT 17 - (NewsRx.com) -- InterMune Pharmaceuticals (ITMN) announced that it plans to initiate a clinical trial evaluating the safety and efficacy of Actimmune(R) (Interferon gamma-1b) Injection as part of first-line therapy for...

Sm-Like Oncogene is Novel Target for Gene Therapy.
October 17, 2000... 2000 OCT 17 - (NewsRx.com) -- The cancer-associated Sm-like oncogene may be an ideal target for gene therapy of pancreatic cancer. "The prognosis for pancreatic cancer (PC) remains dismal, providing a clear need for the development of...

p53 Adenovirus-Mediated Transfer Suppresses Primary Tumor Growth and Metastasis.
October 17, 2000... 2000 OCT 17 - (NewsRx.com) -- Recent research from the United States showed that adenovirus-mediated p53 gene transfer suppressed primary tumor growth and progression to metastasis in animal models. "Numerous advances have been made...

Macrophages Important to Tumor Pathology but Don't Predict Future.
October 17, 2000... 2000 OCT 17 - (NewsRx.com) -- Although tumor-associated macrophages (TAM) are important in influencing the pathogenesis of prostate cancer tumors, scientists say they cannot find any evidence that TAM are good prognostic indicators,...

Therapeutic Vaccine Selected for Human Testing.
October 17, 2000... 2000 OCT 17 - (NewsRx.com) -- Progenics Pharmaceuticals, Inc. (PGNX), Lake Tahoe, Nevada, and Cytogen Corp. (CYTO) announced a vaccine candidate that the companies will develop for the treatment of prostate cancer. The vaccine is...

Cancer Cells Walk the Tightrope.
October 31, 2000... 2000 OCT 31 - (NewsRx.com) -- Researchers have shown that the well known tumor-suppressor gene p53 and its lesser-known cousin, p73, are controlled by the same activation switch. Flipping the activation switch begins a process that...

Long-Term Hormone Plus Radiation Therapy Can Prevent Recurrence.
October 31, 2000... 2000 OCT 31 - (NewsRx.com) -- Long-term hormone treatment plus radiation in locally advanced prostate cancer can prevent recurrence and improve survival, a new study shows. The study by the Radiation Therapy Oncology Group was the...

Vitamin E and Similar Compounds Cause Prostate Cancer Cell Self-Destruction.
October 31, 2000... 2000 OCT 31 - (NewsRx.com) -- New research conducted by investigators at the University of Utah School of Medicine in Salt Lake City has revealed that some antioxidants such as vitamin E can influence the death of prostate cancer cells....

Patients with Cancer Use Active Coping Behavior When Seeking Other Treatments.
October 31, 2000... 2000 OCT 31 - (NewsRx.com) -- Some patients with cancer choose to augment their traditional therapies with complementary and alternative medicine (CAM). Instead of exhibiting behaviors that are associated with poor social or...

Paclitaxel/Ceramide Combination May Be Effective Treatment.
October 31, 2000... 2000 OCT 31 - (NewsRx.com) -- Early studies show that the combination of the cytotoxic drug paclitaxel with the sphingosine ceramide has the potential to be an effective treatment squamous cell carcinomas of the head and neck, according...

Malotilate Makes Lung Cells Form Protective Junctions Against Cancer Cells.
October 31, 2000... 2000 OCT 31 - (NewsRx.com) -- A substance called malotilate can make lung cells aggregate by forming tightly bound cell junctions and creating a barrier against oral squamous carcinoma cells, researchers report in the September-October...

Extract from Aegle marmelos Protects Against Chemical Carcinogenesis.
October 31, 2000... 2000 OCT 31 - (NewsRx.com) -- New research results show that an alcohol extract from leaves of the Aegle marmelos plant not only exhibits antioxidant properties, but can be protective against chemically induced carcinogenesis. The...

Cell Nuclear Receptors Influence Action of Retinoid Compounds on Tumor Death.
October 31, 2000... 2000 OCT 31 - (NewsRx.com) -- Recent studies have focused on the use of retinoic acid and other retinoid compounds in the fight against cancer. A study published in the October 2000 edition of the Journal of Cellular Physiology focuses on...

Erectile Function Better Maintained Following Radiation Therapy Compared to Surgery.
October 31, 2000... 2000 OCT 31 - (NewsRx.com) -- From a psychologist's point of view, prostate cancer patients who are offered radiation therapy as a treatment option should seriously consider it. Patients who can obtain and maintain an erection for...

Sexuality and Spikes: Issues for Clinicians and Cancer Patients.
October 31, 2000... 2000 OCT 31 - (NewsRx.com) -- Sexuality and cancer, and breaking bad news to cancer patients are two featured articles in the journal The Oncologist (vol. 5, no. 4, 2000). Both articles address the increasing importance of...

NIH Branch Awards Grants to Establish Two Specialized Cancer Research Centers.
October 31, 2000... 2000 OCT 31 - (NewsRx.com) -- The National Center for Complementary and Alternative Medicine (NCCAM), a component of the U.S. National Institutes of Health (NIH) announced plans to establish two specialized centers to conduct basic and...

Essential Enzyme Targeted to Kill Cancer Cells While Sparing Normal Cells.
October 31, 2000... 2000 OCT 31 - (NewsRx.com) -- Scientists at The University of Texas M.D. Anderson Cancer Center in Houston have identified an essential enzyme as a novel target to kill cancer cells while sparing normal cells. Findings of the...

Physicians' Group Warns of Milk/Cancer Link.
October 31, 2000... 2000 OCT 31 - (NewsRx.com) -- The Physicians Committee for Responsible Medicine (PCRM) launched an ad campaign in September 2000 in the U.S. that tackled the little-known link between dairy consumption and prostate cancer. The ads -...

FDA Approves Targeted Radiation Technology.
October 31, 2000... 2000 OCT 31 - (NewsRx.com) -- Mankind will soon have another weapon in the 4,000-year fight against cancer. Clearance has been granted by the U.S. Food and Drug Administration for an advanced method for targeting tumors with radiation...

New Gene Identified.
October 31, 2000... 2000 OCT 31 - (NewsRx.com) -- Researchers at Mayo Clinic, Rochester, Minnesota, have discovered that mutations in a newly isolated gene, AXIN2, lead to the development of colorectal cancer. This gene belongs to an important cell...

Cancer Specialist Calls for Proper Clinical Trials.
October 31, 2000... 2000 OCT 31 - (NewsRx.com) -- The conflict between conventional and complementary cancer treatment may be resolved if only both sides could find a way of organizing properly funded, high quality clinical trials, attendees at a cancer...

Chromosome 22q Abnormality Associated with Elevated Risk.
October 31, 2000... 2000 OCT 31 - (NewsRx.com) -- Missing alleles at chromosome 22q can indicate reduced function of a tumor suppression gene and an increased risk for squamous cell head and neck carcinomas, according to a report in Head and Neck - Journal...

VEGF Expression Causes Benign Brain Tumors to Recur after Surgery.
October 31, 2000... 2000 OCT 31 - (NewsRx.com) -- Microscopic pieces of brain tumor that remain following surgery secrete vascular endothelial growth factor (VEGF). These tumors, called meningiomas, sometimes recur in some patients because of VEGF,...

Cyclooxygenase-2 Suppression Inhibits Angiogenesis in Tumors.
October 31, 2000... 2000 OCT 31 - (NewsRx.com) -- Researchers at CUNY Mount Sinai School of Medicine report that by suppressing the expression of cyclooxygenase (COX)-2, prostate cancer tumor growth can be inhibited through apoptotic and anti-angiogenesis...

Low Blood Hemoglobin Levels May Reduce Radiosensitivity.
October 31, 2000... 2000 OCT 31 - (NewsRx.com) -- Researchers in Germany suggested that low blood hemoglobin levels may reduced the sensitivity of normal tissue to radiotherapy. M. Henke and colleagues at University of Freiburg evaluated "the influence...

Transforming Growth Factor-alpha Associates with Hepatocytes in Liver Cancers.
October 31, 2000... 2000 OCT 31 - (NewsRx.com) -- More new evidence that transforming growth factor (TGF)-alpha is significantly expressed in the livers of patients with hepatocellular carcinoma (HCC) has been found by researchers at the Asan Medical Center...

Phosphoinositide-3 Kinase Pathway is used for Pleiotrophin Stimulation.
October 31, 2000... 2000 OCT 31 - (NewsRx.com) -- The 11(th) Annual Meeting of the Extracorporeal Life Support Meeting was recently convened in New Orleans, Louisiana. Scientists and medical investigators presented research reports on a variety of scientific...